-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on IDEXX Laboratories, Raises Price Target to $810

Benzinga·11/03/2026 17:35:21
Listen to the news
Morgan Stanley analyst Erin Wright maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $805 to $810.